However, several reports in the literature have shown that HIV (5–8) and melanoma (9) patients treated with IL2, experience an increase in CD4+ CD25+ FoxP3+ regulatory T cells, which typically mediate natural immune tolerance. The gene discussed is IL2; the disease is melanoma.